4//SEC Filing
SCHMIDT ERIC THOMAS 4
Accession 0001214659-21-003603
CIK 0001737287other
Filed
Mar 29, 8:00 PM ET
Accepted
Mar 30, 4:51 PM ET
Size
7.7 KB
Accession
0001214659-21-003603
Insider Transaction Report
Form 4
SCHMIDT ERIC THOMAS
Chief Financial Officer
Transactions
- Award
Common Stock
2021-03-26+24,866→ 96,097 total - Award
Stock Option (Right to Buy)
2021-03-26+92,365→ 92,365 totalExercise: $33.78Exp: 2031-03-26→ Common Stock (92,365 underlying)
Holdings
- 1,152,595(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]The securities are held in the name of the Eric Schmidt 2017 Family Irrevocable Trust.
- [F2]25% of the shares subject to the stock option shall vest on March 13, 2022, and the remaining shares shall vest in 36 equal monthly installments thereafter.
Documents
Issuer
Allogene Therapeutics, Inc.
CIK 0001737287
Entity typeother
Related Parties
1- filerCIK 0001754403
Filing Metadata
- Form type
- 4
- Filed
- Mar 29, 8:00 PM ET
- Accepted
- Mar 30, 4:51 PM ET
- Size
- 7.7 KB